Chronic Kidney Disease, commonly known as CKD, is a long-term condition where the kidneys gradually lose their ability to filter waste products and excess fluid from the blood. Unlike acute kidney injury, which happens suddenly and can often be completely reversed, CKD develops slowly over months or years. In a maternity and general healthcare setting, understanding this condition is vital because pregnancy can unmask mild, undiagnosed kidney disease or drastically worsen existing renal impairment. When the kidneys fail, harmful toxins build up in the bloodstream, leading to widespread damage across multiple organ systems. Midwives and nurses must recognize that managing CKD requires patience, continuous monitoring, and a deep understanding of how failing kidneys affect fluid balance, blood pressure, and red blood cell production.
The fundamental problem in CKD is the destruction of nephrons, the microscopic filtering units of the kidneys. When a significant number of nephrons are damaged by disease, the remaining healthy nephrons try to compensate by working harder. They increase their workload and filter larger volumes of blood, a process called hyperfiltration. While this compensation keeps the body alive in the short term, it places high pressure inside the delicate filtering clusters, known as the glomeruli. Over time, this constant strain causes the remaining nephrons to scar and die off as well. This creates a vicious cycle of progressive nephron loss, driving the disease inexorably toward end-stage renal failure regardless of whether the initial trigger has stopped.
In Nigeria and across sub-Saharan Africa, the leading drivers of Chronic Kidney Disease differ somewhat from Western nations, though global causes are also rising.
Clinicians stage Chronic Kidney Disease to determine how much function remains and to guide treatment plans. This staging relies primarily on the estimated Glomerular Filtration Rate, abbreviated as eGFR, alongside the presence of protein in the urine, known as proteinuria.
| Stage | eGFR (mL/min/1.73m²) | Description | |
|---|---|---|---|
| --- | --- | --- | > |
| Stage 1 | 90 or higher | Kidney damage with normal or high GFR | |
| Stage 2 | 60 to 89 | Mild decrease in GFR | |
| Stage 3 | 30 to 59 | Moderate decrease in GFR | |
| Stage 4 | 15 to 29 | Severe decrease in GFR | |
| Stage 5 | Less than 15 | Kidney failure or end-stage renal disease |
Persistent protein in the urine is an early warning sign because healthy filters do not allow large protein molecules to slip through.
When the kidneys fail to filter waste, toxins accumulate throughout the body, causing symptoms in almost every organ system. Nurses must watch out for signs of uremia, which is the buildup of waste products in the blood. Fluid overload leads to peripheral swelling in the legs and ankles, as well as pulmonary congestion causing breathlessness. A lack of the hormone erythropoietin causes anemia, leaving patients pale, weak, and chronically fatigued. Electrolyte imbalances, particularly high potassium levels, can trigger dangerous irregular heartbeats. Patients may also complain of severe itching due to mineral and bone disorders, persistent nausea, and a metallic taste in the mouth.
Diagnosing and monitoring CKD relies on a combination of blood tests, urine analysis, and imaging studies. Serum creatinine and blood urea nitrogen are key blood markers that rise when kidney function declines. Serum creatinine is used alongside age and sex to calculate the eGFR. Urinalysis checks for blood cells and quantifies proteinuria using a spot urine protein-to-creatinine ratio or a 24-hour urine collection. Renal ultrasound is frequently performed to visualize the kidneys; in chronic disease, the kidneys often appear abnormally small and shrunken with scarred tissue, unlike the normal size seen in acute kidney injury.
While CKD cannot be cured once advanced, medical management aims to slow its progression and control complications. Blood pressure control is paramount, usually achieved using ACE inhibitors or ARBs, which also help reduce protein loss in the urine. Diuretics manage fluid overload and swelling. Dietary adjustments are equally critical: patients must restrict dietary sodium to control blood pressure, limit potassium to prevent dangerous heart rhythms, and moderate phosphorus intake to protect their bones. Protein intake may also be restricted in earlier stages to reduce the filtering workload on remaining nephrons.
When a patient reaches end-stage renal disease, nursing care shifts toward preparation for renal replacement therapies such as dialysis or kidney transplantation, alongside palliative comfort measures. Nurses monitor daily fluid balance meticulously by recording accurate intake and output, tracking daily weights, and inspecting the body for edema. Patient education focuses on teaching adherence to complex medication schedules, recognizing signs of fluid overload or high potassium, and caring for vascular access sites like arteriovenous fistulas. Providing compassionate emotional support helps patients and their families cope with the life-altering lifestyle changes required by long-term dialysis.